{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:19:25Z","timestamp":1780589965261,"version":"3.54.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Guizhou Provincial Science and Technology Fund","award":["Guizhou Kehe foundation-zk [2022] general 438"],"award-info":[{"award-number":["Guizhou Kehe foundation-zk [2022] general 438"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82203871"],"award-info":[{"award-number":["82203871"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471385"],"award-info":[{"award-number":["82471385"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Guizhou Province Scientific and Technological Innovation Talent Team Project","award":["Qiankeherencai CXTD [2025]048"],"award-info":[{"award-number":["Qiankeherencai CXTD [2025]048"]}]},{"name":"Key Laboratory of Higher Education schools in Guizhou Province","award":["Qianjiaoji [2023]016"],"award-info":[{"award-number":["Qianjiaoji [2023]016"]}]},{"name":"Guizhou Province's Key Project of the National Natural Science Foundation Basic Research Program","award":["Qiankehejichu ZD[2025]065"],"award-info":[{"award-number":["Qiankehejichu ZD[2025]065"]}]},{"name":"Guizhou Province's Scientist Workstation Project","award":["Qiankehepingtai KXJZ [2024]004"],"award-info":[{"award-number":["Qiankehepingtai KXJZ [2024]004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03645-7","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:17:28Z","timestamp":1764915448000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["VSIG2 as a novel immunosuppressive ligand interacts with Nectin-2 to regulate T cell responses"],"prefix":"10.1186","volume":"23","author":[{"given":"Xianbin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kezhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keke","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuandi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yishen","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangshi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laijun","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"issue":"3","key":"3645_CR1","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1084\/jem.174.3.625","volume":"174","author":"GJ Freeman","year":"1991","unstructured":"Freeman GJ, Gray GS, Gimmi CD, Lombard DB, Zhou LJ, White M, et al. Structure, expression, and T cell costimulatory activity of the murine homologue of the human B lymphocyte activation antigen B7. J Exp Med. 1991;174(3):625\u201331.","journal-title":"J Exp Med"},{"issue":"5135","key":"3645_CR2","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1126\/science.7694363","volume":"262","author":"GJ Freeman","year":"1993","unstructured":"Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr., Lombard LA, et al. Cloning of B7-2: a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science. 1993;262(5135):909\u201311.","journal-title":"Science"},{"issue":"7","key":"3645_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1084\/jem.192.7.1027","volume":"192","author":"GJ Freeman","year":"2000","unstructured":"Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, et al. Engagement of the PD-1 Immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med. 2000;192(7):1027\u201334.","journal-title":"J Exp Med"},{"issue":"3","key":"3645_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/85330","volume":"2","author":"Y Latchman","year":"2001","unstructured":"Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol. 2001;2(3):261\u20138.","journal-title":"Nat Immunol"},{"issue":"8","key":"3645_CR5","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1182\/blood.V96.8.2808","volume":"96","author":"S Wang","year":"2000","unstructured":"Wang S, Zhu G, Chapoval AI, Dong H, Tamada K, Ni J, et al. Costimulation of T cells by B7-H2, a B7-like molecule that binds ICOS. Blood. 2000;96(8):2808\u201313.","journal-title":"Blood"},{"issue":"3","key":"3645_CR6","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/85339","volume":"2","author":"AI Chapoval","year":"2001","unstructured":"Chapoval AI, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, et al. B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol. 2001;2(3):269\u201374.","journal-title":"Nat Immunol"},{"issue":"6","key":"3645_CR7","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S1074-7613(03)00152-3","volume":"18","author":"GL Sica","year":"2003","unstructured":"Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity. 2003;18(6):849\u201361.","journal-title":"Immunity"},{"key":"3645_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3043","volume":"4","author":"Y Zhu","year":"2013","unstructured":"Zhu Y, Yao S, Iliopoulou BP, Han X, Augustine MM, Xu H, et al. B7-H5 costimulates human T cells via CD28H. Nat Commun. 2013;4:2043.","journal-title":"Nat Commun"},{"issue":"7","key":"3645_CR9","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1084\/jem.20090681","volume":"206","author":"CS Brandt","year":"2009","unstructured":"Brandt CS, Baratin M, Yi EC, Kennedy J, Gao Z, Fox B, et al. The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans. J Exp Med. 2009;206(7):1495\u2013503.","journal-title":"J Exp Med"},{"issue":"6","key":"3645_CR10","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1038\/s41423-020-0361-7","volume":"18","author":"SA Rieder","year":"2021","unstructured":"Rieder SA, Wang J, White N, Qadri A, Menard C, Stephens G, et al. B7-H7 (HHLA2) inhibits T-cell activation and proliferation in the presence of TCR and CD28 signaling. Cell Mol Immunol. 2021;18(6):1503\u201311.","journal-title":"Cell Mol Immunol"},{"key":"3645_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.938470","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou X, Khan S, Huang D, Li L. V-set and immunoglobulin domain containing (VSIG) proteins as emerging immune checkpoint targets for cancer immunotherapy. Front Immunol. 2022;13:938470.","journal-title":"Front Immunol"},{"issue":"1","key":"3645_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/imm.13001","volume":"156","author":"J Wang","year":"2019","unstructured":"Wang J, Wu G, Manick B, Hernandez V, Renelt M, Erickson C, et al. VSIG-3 as a ligand of VISTA inhibits human T-cell function. Immunology. 2019;156(1):74\u201385.","journal-title":"Immunology"},{"issue":"1","key":"3645_CR13","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41467-017-01327-4","volume":"8","author":"J Li","year":"2017","unstructured":"Li J, Diao B, Guo S, Huang X, Yang C, Feng Z, et al. VSIG4 inhibits proinflammatory macrophage activation by reprogramming mitochondrial pyruvate metabolism. Nat Commun. 2017;8(1):1322.","journal-title":"Nat Commun"},{"issue":"4","key":"3645_CR14","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/eji.1830260409","volume":"26","author":"I Chr\u00e9tien","year":"1996","unstructured":"Chr\u00e9tien I, Robert J, Marcuz A, Garcia-Sanz JA, Courtet M, Du Pasquier L. CTX, a novel molecule specifically expressed on the surface of cortical thymocytes in xenopus. Eur J Immunol. 1996;26(4):780\u201391.","journal-title":"Eur J Immunol"},{"issue":"12","key":"3645_CR15","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s00262-019-02408-7","volume":"68","author":"H Yan","year":"2019","unstructured":"Yan H, Qu J, Cao W, Liu Y, Zheng G, Zhang E, et al. Identification of prognostic genes in the acute myeloid leukemia immune microenvironment based on TCGA data analysis. Cancer Immunol Immunother. 2019;68(12):1971\u20138.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"3645_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01209-x","volume":"21","author":"J Xu","year":"2023","unstructured":"Xu J, Quan G, Huang W, Jiang J. VSIG2 promotes malignant progression of pancreatic ductal adenocarcinoma by enhancing LAMTOR2-mediated mTOR activation. Cell Commun Signal. 2023;21(1):223.","journal-title":"Cell Commun Signal"},{"issue":"4","key":"3645_CR17","doi-asserted-by":"publisher","first-page":"R151","DOI":"10.1186\/ar3101","volume":"12","author":"SN Kariuki","year":"2010","unstructured":"Kariuki SN, Franek BS, Kumar AA, Arrington J, Mikolaitis RA, Utset TO, et al. Trait-stratified genome-wide association study identifies novel and diverse genetic associations with serologic and cytokine phenotypes in systemic lupus erythematosus. Arthritis Res Ther. 2010;12(4):R151.","journal-title":"Arthritis Res Ther"},{"key":"3645_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jprot.2020.103995","volume":"231","author":"YN Chai","year":"2021","unstructured":"Chai YN, Qin J, Li YL, Tong YL, Liu GH, Wang XR, et al. TMT proteomics analysis of intestinal tissue from patients of irritable bowel syndrome with diarrhea: implications for multiple nutrient ingestion abnormality. J Proteomics. 2021;231:103995.","journal-title":"J Proteomics"},{"issue":"1","key":"3645_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.2215\/CJN.09380721","volume":"17","author":"IM Schmidt","year":"2022","unstructured":"Schmidt IM, Sarvode Mothi S, Wilson PC, Palsson R, Srivastava A, Onul IF, et al. Circulating plasma biomarkers in Biopsy-Confirmed kidney disease. Clin J Am Soc Nephrol. 2022;17(1):27\u201337.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"21","key":"3645_CR20","doi-asserted-by":"publisher","first-page":"3335","DOI":"10.1182\/blood-2014-09-603357","volume":"125","author":"RG Veenstra","year":"2015","unstructured":"Veenstra RG, Flynn R, Kreymborg K, McDonald-Hyman C, Saha A, Taylor PA, et al. B7-H3 expression in donor T cells and host cells negatively regulates acute graft-versus-host disease lethality. Blood. 2015;125(21):3335\u201346.","journal-title":"Blood"},{"issue":"12","key":"3645_CR21","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<4094::AID-IMMU4094>3.0.CO;2-2","volume":"28","author":"I Chr\u00e9tien","year":"1998","unstructured":"Chr\u00e9tien I, Marcuz A, Courtet M, Katevuo K, Vainio O, Heath JK, et al. CTX, a Xenopus thymocyte receptor, defines a molecular family conserved throughout vertebrates. Eur J Immunol. 1998;28(12):4094\u2013104.","journal-title":"Eur J Immunol"},{"issue":"1","key":"3645_CR22","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13045-021-01085-3","volume":"14","author":"JA Marin-Acevedo","year":"2021","unstructured":"Marin-Acevedo JA, Kimbrough EO, Manochakian R, Zhao Y, Lou Y. Immunotherapies targeting stimulatory pathways and beyond. J Hematol Oncol. 2021;14(1):78.","journal-title":"J Hematol Oncol"},{"issue":"1","key":"3645_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12943-023-01740-y","volume":"22","author":"A Lahiri","year":"2023","unstructured":"Lahiri A, Maji A, Potdar PD, Singh N, Parikh P, Bisht B, et al. Lung cancer immunotherapy: progress, pitfalls, and promises. Mol Cancer. 2023;22(1):40.","journal-title":"Mol Cancer"},{"issue":"4","key":"3645_CR24","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen L, Flies DB. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013;13(4):227\u201342.","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"3645_CR25","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022111556","volume":"42","author":"A Kennedy","year":"2023","unstructured":"Kennedy A, Robinson MA, Hinze C, Waters E, Williams C, Halliday N, et al. The CTLA-4 immune checkpoint protein regulates PD-L1:PD-1 interaction via transendocytosis of its ligand CD80. EMBO J. 2023;42(5):e111556.","journal-title":"EMBO J"},{"issue":"1","key":"3645_CR26","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1038\/s41467-022-29930-0","volume":"13","author":"W Piao","year":"2022","unstructured":"Piao W, Li L, Saxena V, Iyyathurai J, Lakhan R, Zhang Y, et al. PD-L1 signaling selectively regulates T cell lymphatic transendothelial migration. Nat Commun. 2022;13(1):2176.","journal-title":"Nat Commun"},{"issue":"5","key":"3645_CR27","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.immuni.2020.04.011","volume":"52","author":"MEW Logtenberg","year":"2020","unstructured":"Logtenberg MEW, Scheeren FA, Schumacher TN. The CD47-SIRP\u03b1 immune checkpoint. Immunity. 2020;52(5):742\u201352.","journal-title":"Immunity"},{"issue":"9","key":"3645_CR28","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1038\/s41590-023-01569-z","volume":"24","author":"V Aggarwal","year":"2023","unstructured":"Aggarwal V, Workman CJ, Vignali DAA. LAG-3 as the third checkpoint inhibitor. Nat Immunol. 2023;24(9):1415\u201322.","journal-title":"Nat Immunol"},{"key":"3645_CR29","doi-asserted-by":"crossref","unstructured":"Braun E, Hotter D, Koepke L, Zech F, Gro\u00df R, Sparrer KMJ et al. Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. Cell reports, 2019, 27 (7): 2092\u20132104.e2010.","DOI":"10.1016\/j.celrep.2019.04.063"},{"issue":"12","key":"3645_CR30","doi-asserted-by":"publisher","first-page":"e14246","DOI":"10.1371\/journal.pone.0014246","volume":"5","author":"N Britzen-Laurent","year":"2010","unstructured":"Britzen-Laurent N, Bauer M, Berton V, Fischer N, Syguda A, Reipschl\u00e4ger S, et al. Intracellular trafficking of guanylate-binding proteins is regulated by heterodimerization in a hierarchical manner. PLoS One. 2010;5(12):e14246.","journal-title":"PLoS One"},{"issue":"3","key":"3645_CR31","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41590-021-01125-7","volume":"23","author":"D Sugiura","year":"2022","unstructured":"Sugiura D, Okazaki IM, Maeda TK, Maruhashi T, Shimizu K, Arakaki R, et al. PD-1 agonism by anti-CD80 inhibits T cell activation and alleviates autoimmunity. Nat Immunol. 2022;23(3):399\u2013410.","journal-title":"Nat Immunol"},{"issue":"2","key":"3645_CR32","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1084\/jem.20150785","volume":"213","author":"Y Zhu","year":"2016","unstructured":"Zhu Y, Paniccia A, Schulick AC, Chen W, Koenig MR, Byers JT, et al. Identification of CD112R as a novel checkpoint for human T cells. J Exp Med. 2016;213(2):167\u201376.","journal-title":"J Exp Med"},{"issue":"6","key":"3645_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1084\/jem.20112741","volume":"209","author":"T Yokosuka","year":"2012","unstructured":"Yokosuka T, Takamatsu M, Kobayashi-Imanishi W, Hashimoto-Tane A, Azuma M, Saito T. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J Exp Med. 2012;209(6):1201\u201317.","journal-title":"J Exp Med"},{"issue":"1","key":"3645_CR34","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12943-023-01751-9","volume":"22","author":"AA Getu","year":"2023","unstructured":"Getu AA, Tigabu A, Zhou M, Lu J, Fodstad \u00d8, Tan M. New frontiers in immune checkpoint B7-H3 (CD276) research and drug development. Mol Cancer. 2023;22(1):43.","journal-title":"Mol Cancer"},{"issue":"12","key":"3645_CR35","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1038\/nrd4476","volume":"13","author":"RM Webster","year":"2014","unstructured":"Webster RM. The immune checkpoint inhibitors: where are we now? Nat Rev Drug Discov. 2014;13(12):883\u20134.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"3645_CR36","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1093\/annonc\/mdv615","volume":"27","author":"J Chen","year":"2016","unstructured":"Chen J, Jiang CC, Jin L, Zhang XD. Regulation of PD-L1: a novel role of pro-survival signalling in cancer. Ann Oncol. 2016;27(3):409\u201316.","journal-title":"Ann Oncol"},{"issue":"1","key":"3645_CR37","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/j.1600-065X.2009.00773.x","volume":"229","author":"JR Podojil","year":"2009","unstructured":"Podojil JR, Miller SD. Molecular mechanisms of T-cell receptor and costimulatory molecule ligation\/blockade in autoimmune disease therapy. Immunol Rev. 2009;229(1):337\u201355.","journal-title":"Immunol Rev"},{"issue":"1","key":"3645_CR38","doi-asserted-by":"publisher","first-page":"5555","DOI":"10.1038\/s41467-023-40982-8","volume":"14","author":"M Linnerbauer","year":"2023","unstructured":"Linnerbauer M, Beyer T, Nirschl L, Farrenkopf D, L\u00f6\u00dflein L, Vandrey O, et al. PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation. Nat Commun. 2023;14(1):5555.","journal-title":"Nat Commun"},{"issue":"12","key":"3645_CR39","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/s41573-020-0081-9","volume":"19","author":"NM Edner","year":"2020","unstructured":"Edner NM, Carlesso G, Rush JS, Walker LSK. Targeting co-stimulatory molecules in autoimmune disease. Nature reviews Drug discovery. 2020;19(12):860\u201383.","journal-title":"Nature reviews. Drug discovery"},{"key":"3645_CR40","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ctrv.2017.01.009","volume":"54","author":"CY Ok","year":"2017","unstructured":"Ok CY, Young KH. Targeting the programmed death-1 pathway in lymphoid neoplasms. Cancer Treat Rev. 2017;54:99\u2013109.","journal-title":"Cancer Treat Rev"},{"issue":"8","key":"3645_CR41","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1038\/s41423-020-0494-8","volume":"18","author":"M Su","year":"2021","unstructured":"Su M, Lin Y, Cui C, Tian X, Lai L. ERMAP is a B7 family-related molecule that negatively regulates T cell and macrophage responses. Cell Mol Immunol. 2021;18(8):1920\u201333.","journal-title":"Cell Mol Immunol"},{"key":"3645_CR42","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.imlet.2023.06.009","volume":"260","author":"Y Huang","year":"2023","unstructured":"Huang Y, Han F, Li J, Li Y, Gao J, Lai L, et al. BTN2A2-Ig protein inhibits the differentiation of pathogenic Th17 cells and attenuates EAE in mice. Immunol Lett. 2023;260:58\u201367.","journal-title":"Immunol Lett"},{"issue":"8009","key":"3645_CR43","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/s41586-024-07251-0","volume":"628","author":"Y Gu","year":"2024","unstructured":"Gu Y, Bartolom\u00e9-Casado R, Xu C, Bertocchi A, Janney A, Heuberger C, et al. Immune microniches shape intestinal T(reg) function. Nature. 2024;628(8009):854\u201362.","journal-title":"Nature"},{"issue":"5","key":"3645_CR44","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1136\/gutjnl-2022-327183","volume":"72","author":"H Lu","year":"2023","unstructured":"Lu H, Zhang C, Wu W, Chen H, Lin R, Sun R, et al. MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis. Gut. 2023;72(5):882\u201395.","journal-title":"Gut"},{"issue":"6","key":"3645_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41571-021-00473-5","volume":"18","author":"DB Doroshow","year":"2021","unstructured":"Doroshow DB, Bhalla S, Beasley MB, Sholl LM, Kerr KM, Gnjatic S, et al. PD-L1 as a biomarker of response to immune-checkpoint inhibitors. Nat Rev Clin Oncol. 2021;18(6):345\u201362.","journal-title":"Nat Rev Clin Oncol"},{"key":"3645_CR46","doi-asserted-by":"crossref","unstructured":"Su M, Song Y, He Z, Hu R, Rood D, Lai L. Administration of embryonic stem cell-derived thymic epithelial progenitors expressing MOG induces antigen-specific tolerance and ameliorates experimental autoimmune encephalomyelitis. J. Autoimmun., 2015, 58 36-47","DOI":"10.1016\/j.jaut.2015.01.002"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03645-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03645-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03645-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:56:56Z","timestamp":1768474616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-025-03645-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3645"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03645-7","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]},"assertion":[{"value":"9 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}